Family finances

Who is the breadwinner in your family and does it matter?

Neurocrine Biosciences, Inc. (NBIX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

142.11

+4.57

(+3.32%)

As of 10:23AM EDT. Market open.

Loading interactive chart…

Investor's Business Daily
No. 1 Biotech Stock Neurocrine Pops After Its Biggest Moneymaker Snatches Another Win
Neurocrine stock jumped early Wednesday after the company's biggest moneymaker, Ingrezza, topped first-quarter sales forecasts.
Zacks
Neurocrine Biosciences (NBIX) Q1 Earnings Miss Estimates
Neurocrine (NBIX) delivered earnings and revenue surprises of -59.62% and 0.60%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
PR Newswire
Neurocrine Biosciences Reports First Quarter 2024 Financial Results
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the first quarter ended March 31, 2024 and provided an update on its 2024 financial guidance.